C3 and C3a as indicators of complement dysregulation in tauopathies and FTLD-associated disorders
Laura Nicholls(Cardiff University), Wioleta M. Zelek(UK Dementia Research Institute), James B. Rowe(MRC Cognition and Brain Sciences Unit), Jacqui Nimmo(UK Dementia Research Institute), B. Paul Morgan(UK Dementia Research Institute), Robert A.J. Byrne(Cardiff University), Rebekah S. Cooke(Cardiff University), Samuel Keat(UK Dementia Research Institute), Taine J. Baggott(Cardiff University), Gareth D. Fenn(Cardiff University), Maura Malpetti(University of Cambridge), Weronika J. Forys(University of Cambridge), John T. O’Brien(Addenbrooke's Hospital)
Cited by 2
Related Papers
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Research criteria for the diagnosis of prodromal dementia with Lewy bodies
|Neurology|2020|772
Vascular dysfunction—The disregarded partner of Alzheimer's disease
|Alzheimer s & Dementia|2019|721